• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, September 8, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home Headlines

Can CranioSacral therapy improve symptoms of concussion & mild TBI…

Bioengineer.org by Bioengineer.org
January 31, 2018
in Headlines, Health, Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Mary Ann Liebert, Inc., publishers

New Rochelle, NY, January 9, 2018– This invited commentary references a preliminary study in which the integrative medicine technique known as CranioSacral Therapy (CST) was tested on a group of ex-National Football League (NFL) players who showed significant improvement in range of motion, pain, sleep, and cognitive function. The need for more clinical research data to better understand the potential effectiveness of CST in post-concussive syndrome, mild and more severe traumatic brain injury, and even perhaps chronic traumatic encephalopathy (CTE) is emphasized in the article published in the Journal of Alternative and Complementary Medicine (JACM), a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on JACM website until February 9, 2018.

Eric Leskowitz, MD, Integrative Medicine Task Force, Spaulding Rehabilitation Hospital, Charlestown, MA describes the technique involved in CST in his commentary entitled "CranioSacral Therapy, Brain Injury, and American Football: Time for a Convergence." The therapy involves applying gentle pressure on specific sites on the skull to release restrictions believed to have been caused by head trauma. These restrictions are thought to impair brain function and neuronal repair by altering the rhythmic pulsation and circulation of the cerebrospinal fluid. Dr. Leskowitz highlights the growing need for new treatments for TBI increasingly recognized in football players and among military personnel experiencing blast injuries, and for post-concussive syndrome and the rapidly emerging problem of CTE among professional football players.

"We recognize that these data cited by Dr. Leskowitz are quite preliminary, and at the same time we are all aware since the 2015 movie 'Concussion' of the magnitude of the problem in football," says JACM Editor-in-Chief John Weeks, johnweeks-integrator.com, Seattle, WA. He adds: "The situation supports drawing attention to the potential – as this commentary does – so that researchers may more quickly be called to examine this treatment option more thoroughly."

###

About the Journal

The Journal of Alternative and Complementary Medicine (JACM) is a monthly peer-reviewed journal published online with open access options and in print. Led by John Weeks (johnweeks-integrator.com), the Co-founder and past Executive Director of the Academic Collaborative for Integrative Health, JACM provides observational, clinical, and scientific reports and commentary intended to help healthcare professionals, delivery organization leaders, and scientists evaluate and integrate therapies into patient care protocols and research strategies. Complete tables of content and a sample issue may be viewed on JACM website.

About the Publisher

Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Alternative and Complementary Therapies, Medical Acupuncture, and Journal of Medicinal Food. Its biotechnology trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.

Media Contact

Kathryn Ryan
[email protected]
914-740-2250
@LiebertPub

http://www.liebertpub.com

Original Source

http://www.liebertpub.com/global/pressrelease/can-craniosacral-therapy-improve-symptoms-of-concussion-and-mild-traumatic-brain-injury-among-football-players/2317/ http://dx.doi.org/10.1089/acm.2017.0264

Share12Tweet7Share2ShareShareShare1

Related Posts

Tarlatamab Combined with Anti-PD-L1 Shows Promising Safety and Unprecedented Overall Survival as First-Line Maintenance Therapy Following Chemo-Immunotherapy in ES-SCLC

September 8, 2025
Quorum Quenching Beta-Lactamase from Chromohalobacter Sp.

Quorum Quenching Beta-Lactamase from Chromohalobacter Sp.

September 8, 2025

X-ray Insights on Elodontomas in South African Rodents

September 8, 2025

New Clinical Study Advances Understanding of Mesothelioma and Unveils Potential Treatment Pathways

September 8, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    150 shares
    Share 60 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • First Confirmed Human Mpox Clade Ib Case China

    56 shares
    Share 22 Tweet 14
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    47 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Tarlatamab Combined with Anti-PD-L1 Shows Promising Safety and Unprecedented Overall Survival as First-Line Maintenance Therapy Following Chemo-Immunotherapy in ES-SCLC

Quorum Quenching Beta-Lactamase from Chromohalobacter Sp.

X-ray Insights on Elodontomas in South African Rodents

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.